Radiologist-Integrated Finite Element Framework for Acromial Stress in Reverse Shoulder Arthroplasty

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60-80
SponsorUniversity of Molise

About this trial

The current prospective single-center study is designed to examine an approach that utilizes both high-resolution CT and MRI scans, coupled with customized finite element modelling to analyze the stress placed on the acromion of patients who have undergone RSA surgery. The degree of rotator cuff deficiency will be assessed using Goutallier classification and quantified as Cuff Deficiency Index (CDI), which directly provides biomechanical information for calculating deltoid forces used in finite element analysis. Von Mises stresses will then be analyzed in anatomically defined acromial zones (Levy zones I-III).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients (60-80 years) with cuff tear arthropathy (Hamada grade 3 or above, Walch glenoid B/C) scheduled for primary unilateral reverse shoulder arthroplasty

Availability of preoperative high-resolution CT (voxel 1 mm or less) and 1.5T/3T MRI

Written informed consent for prospective use of anonymised data

Disqualifiers

Revision RSA or history of prior shoulder prosthetic complications

Uncorrectable imaging artefacts

Post-RSA follow-up shorter than 6 months

Trial population

Consecutive elective RSA candidates at a single orthopaedic centre

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Regional von Mises stress within acromial Levy zones

95th percentile of von Mises stress extracted from patient-specific finite element models within anatomically defined Levy classification zones of the acromion

Time frame
6 months post-surgery

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: